Disease	O
Activity	O
and	O
Increased	B:C0332167
Risk	I:C0332167
of	I:C0332167
Cardiovascular	O
Death	I:C0376297
among	O
Patients	O
with	O
Psoriatic	O
Arthritis	I:C0003872
.	O

Disease	O
Activity	O
and	O
Increased	O
Risk	I:C0332167
of	I:C0332167
Cardiovascular	B:C0376297
Death	I:C0376297
among	O
Patients	O
with	O
Psoriatic	O
Arthritis	I:C0003872
.	O

Disease	O
Activity	O
and	O
Increased	O
Risk	I:C0332167
of	I:C0332167
Cardiovascular	O
Death	I:C0376297
among	O
Patients	O
with	O
Psoriatic	B:C0003872
Arthritis	I:C0003872
.	O

Recent	O
studies	O
indicate	O
increased	O
cardiovascular	B:C1301700
(	I:C1301700
CV	I:C1301700
)	I:C1301700
morbidity	I:C1301700
and	O
mortality	O
in	O
patients	O
with	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
,	O
but	O
results	O
are	O
inconsistent	O
.	O

Recent	O
studies	O
indicate	O
increased	O
cardiovascular	O
(	I:C1301700
CV	I:C1301700
)	I:C1301700
morbidity	I:C1301700
and	O
mortality	B:C0376297
in	O
patients	O
with	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
,	O
but	O
results	O
are	O
inconsistent	O
.	O

Recent	O
studies	O
indicate	O
increased	O
cardiovascular	O
(	I:C1301700
CV	I:C1301700
)	I:C1301700
morbidity	I:C1301700
and	O
mortality	O
in	O
patients	O
with	O
psoriatic	B:C0003872
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
,	O
but	O
results	O
are	O
inconsistent	O
.	O

Recent	O
studies	O
indicate	O
increased	O
cardiovascular	O
(	I:C1301700
CV	I:C1301700
)	I:C1301700
morbidity	I:C1301700
and	O
mortality	O
in	O
patients	O
with	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	B:C0003872
arthritis	I:C0003872
)	O
,	O
but	O
results	O
are	O
inconsistent	O
.	O

This	O
prompted	O
our	O
investigation	O
of	O
the	O
mortality	O
rate	O
,	O
cause	B:C0007465
of	I:C0007465
death	I:C0007465
,	O
and	O
incidence	O
of	O
acute	O
CV	O
events	I:C1320716
in	O
patients	O
from	O
northern	O
Sweden	O
with	O
psoriatic	O
arthritis	I:C0003872
.	O

This	O
prompted	O
our	O
investigation	O
of	O
the	O
mortality	O
rate	O
,	O
cause	O
of	I:C0007465
death	I:C0007465
,	O
and	O
incidence	O
of	O
acute	O
CV	B:C1320716
events	I:C1320716
in	O
patients	O
from	O
northern	O
Sweden	O
with	O
psoriatic	O
arthritis	I:C0003872
.	O

This	O
prompted	O
our	O
investigation	O
of	O
the	O
mortality	O
rate	O
,	O
cause	O
of	I:C0007465
death	I:C0007465
,	O
and	O
incidence	O
of	O
acute	O
CV	O
events	I:C1320716
in	O
patients	O
from	O
northern	B:C1709269
Sweden	O
with	O
psoriatic	O
arthritis	I:C0003872
.	O

This	O
prompted	O
our	O
investigation	O
of	O
the	O
mortality	O
rate	O
,	O
cause	O
of	I:C0007465
death	I:C0007465
,	O
and	O
incidence	O
of	O
acute	O
CV	O
events	I:C1320716
in	O
patients	O
from	O
northern	O
Sweden	B:C0038995
with	O
psoriatic	O
arthritis	I:C0003872
.	O

This	O
prompted	O
our	O
investigation	O
of	O
the	O
mortality	O
rate	O
,	O
cause	O
of	I:C0007465
death	I:C0007465
,	O
and	O
incidence	O
of	O
acute	O
CV	O
events	I:C1320716
in	O
patients	O
from	O
northern	O
Sweden	O
with	O
psoriatic	B:C0003872
arthritis	I:C0003872
.	O

Patients	O
with	O
established	O
psoriatic	B:C0003872
arthritis	I:C0003872
(	O
464	O
)	O
were	O
included	O
.	O

To	O
calculate	O
standardized	O
mortality	O
ratio	O
(	O
SMR	O
)	O
and	O
standardized	O
incidence	O
ratio	O
(	O
SIR	O
)	O
for	O
CV	B:C1320716
events	I:C1320716
,	O
data	O
were	O
extracted	O
from	O
the	O
National	O
Causes	I:C0282574
of	I:C0282574
Death	I:C0282574
Register	I:C0282574
and	O
the	O
National	O
Inpatient	I:C0282574
Care	I:C0282574
Register	I:C0282574
in	O
Sweden	O
,	O
and	O
compared	O
with	O
the	O
general	O
population	I:C0683971
.	O

To	O
calculate	O
standardized	O
mortality	O
ratio	O
(	O
SMR	O
)	O
and	O
standardized	O
incidence	O
ratio	O
(	O
SIR	O
)	O
for	O
CV	O
events	I:C1320716
,	O
data	O
were	O
extracted	O
from	O
the	O
National	B:C0282574
Causes	I:C0282574
of	I:C0282574
Death	I:C0282574
Register	I:C0282574
and	O
the	O
National	O
Inpatient	I:C0282574
Care	I:C0282574
Register	I:C0282574
in	O
Sweden	O
,	O
and	O
compared	O
with	O
the	O
general	O
population	I:C0683971
.	O

To	O
calculate	O
standardized	O
mortality	O
ratio	O
(	O
SMR	O
)	O
and	O
standardized	O
incidence	O
ratio	O
(	O
SIR	O
)	O
for	O
CV	O
events	I:C1320716
,	O
data	O
were	O
extracted	O
from	O
the	O
National	O
Causes	I:C0282574
of	I:C0282574
Death	I:C0282574
Register	I:C0282574
and	O
the	O
National	B:C0282574
Inpatient	I:C0282574
Care	I:C0282574
Register	I:C0282574
in	O
Sweden	O
,	O
and	O
compared	O
with	O
the	O
general	O
population	I:C0683971
.	O

To	O
calculate	O
standardized	O
mortality	O
ratio	O
(	O
SMR	O
)	O
and	O
standardized	O
incidence	O
ratio	O
(	O
SIR	O
)	O
for	O
CV	O
events	I:C1320716
,	O
data	O
were	O
extracted	O
from	O
the	O
National	O
Causes	I:C0282574
of	I:C0282574
Death	I:C0282574
Register	I:C0282574
and	O
the	O
National	O
Inpatient	I:C0282574
Care	I:C0282574
Register	I:C0282574
in	O
Sweden	B:C0038995
,	O
and	O
compared	O
with	O
the	O
general	O
population	I:C0683971
.	O

To	O
calculate	O
standardized	O
mortality	O
ratio	O
(	O
SMR	O
)	O
and	O
standardized	O
incidence	O
ratio	O
(	O
SIR	O
)	O
for	O
CV	O
events	I:C1320716
,	O
data	O
were	O
extracted	O
from	O
the	O
National	O
Causes	I:C0282574
of	I:C0282574
Death	I:C0282574
Register	I:C0282574
and	O
the	O
National	O
Inpatient	I:C0282574
Care	I:C0282574
Register	I:C0282574
in	O
Sweden	O
,	O
and	O
compared	O
with	O
the	O
general	B:C0683971
population	I:C0683971
.	O

The	O
SMR	O
(	O
95	O
%	O
CI	O
)	O
for	O
overall	O
mortality	O
and	O
diseases	B:C0728936
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
(	O
International	O
Classification	I:C0870733
of	I:C0870733
Diseases	I:C0870733
,	O
10th	O
edition	O
;	O
I00	O
-	O
I99	O
)	O
was	O
1.22	O
(	O
0.89	O
-	O
1.63	O
)	O
and	O
1.64	O
(	O
1.02	O
-	O
2.52	O
)	O
,	O
respectively	O
.	O

The	O
SMR	O
(	O
95	O
%	O
CI	O
)	O
for	O
overall	O
mortality	O
and	O
diseases	O
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
(	O
International	B:C0870733
Classification	I:C0870733
of	I:C0870733
Diseases	I:C0870733
,	O
10th	O
edition	O
;	O
I00	O
-	O
I99	O
)	O
was	O
1.22	O
(	O
0.89	O
-	O
1.63	O
)	O
and	O
1.64	O
(	O
1.02	O
-	O
2.52	O
)	O
,	O
respectively	O
.	O

In	O
regression	B:C0034980
analysis	I:C0034980
,	O
DAI	O
was	O
significantly	O
associated	O
with	O
death	O
(	O
OR	O
1.99	O
,	O
95	O
%	O
CI	O
1.41	O
-	O
2.80	O
)	O
when	O
adjusted	O
for	O
age	O
and	O
sex	O
(	O
p	O
<	O
0.001	O
)	O
,	O
and	O
remained	O
significant	O
after	O
stratifying	O
patients	O
into	O
the	O
2	O
major	O
causes	O
of	I:C0007465
death	I:C0007465
:	O
diseases	O
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
and	O
malignant	O
neoplasms	I:C0006826
.	O

In	O
regression	O
analysis	I:C0034980
,	O
DAI	O
was	O
significantly	O
associated	O
with	O
death	B:C1306577
(	O
OR	O
1.99	O
,	O
95	O
%	O
CI	O
1.41	O
-	O
2.80	O
)	O
when	O
adjusted	O
for	O
age	O
and	O
sex	O
(	O
p	O
<	O
0.001	O
)	O
,	O
and	O
remained	O
significant	O
after	O
stratifying	O
patients	O
into	O
the	O
2	O
major	O
causes	O
of	I:C0007465
death	I:C0007465
:	O
diseases	O
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
and	O
malignant	O
neoplasms	I:C0006826
.	O

In	O
regression	O
analysis	I:C0034980
,	O
DAI	O
was	O
significantly	O
associated	O
with	O
death	O
(	O
OR	O
1.99	O
,	O
95	O
%	O
CI	O
1.41	O
-	O
2.80	O
)	O
when	O
adjusted	O
for	O
age	O
and	O
sex	O
(	O
p	O
<	O
0.001	O
)	O
,	O
and	O
remained	O
significant	O
after	O
stratifying	O
patients	O
into	O
the	O
2	O
major	O
causes	B:C0007465
of	I:C0007465
death	I:C0007465
:	O
diseases	O
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
and	O
malignant	O
neoplasms	I:C0006826
.	O

In	O
regression	O
analysis	I:C0034980
,	O
DAI	O
was	O
significantly	O
associated	O
with	O
death	O
(	O
OR	O
1.99	O
,	O
95	O
%	O
CI	O
1.41	O
-	O
2.80	O
)	O
when	O
adjusted	O
for	O
age	O
and	O
sex	O
(	O
p	O
<	O
0.001	O
)	O
,	O
and	O
remained	O
significant	O
after	O
stratifying	O
patients	O
into	O
the	O
2	O
major	O
causes	O
of	I:C0007465
death	I:C0007465
:	O
diseases	B:C0728936
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
and	O
malignant	O
neoplasms	I:C0006826
.	O

In	O
regression	O
analysis	I:C0034980
,	O
DAI	O
was	O
significantly	O
associated	O
with	O
death	O
(	O
OR	O
1.99	O
,	O
95	O
%	O
CI	O
1.41	O
-	O
2.80	O
)	O
when	O
adjusted	O
for	O
age	O
and	O
sex	O
(	O
p	O
<	O
0.001	O
)	O
,	O
and	O
remained	O
significant	O
after	O
stratifying	O
patients	O
into	O
the	O
2	O
major	O
causes	O
of	I:C0007465
death	I:C0007465
:	O
diseases	O
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
and	O
malignant	B:C0006826
neoplasms	I:C0006826
.	O

Peripheral	B:C1704436
and	O
axial	O
disease	I:C3805913
was	O
associated	O
with	O
death	O
(	O
OR	O
4.02	O
,	O
95	O
%	O
CI	O
1.84	O
-8.84	O
,	O
p	O
<	O
0.001	O
)	O
compared	O
with	O
peripheral	O
disease	I:C1704436
only	O
.	O

Peripheral	O
and	O
axial	B:C3805913
disease	I:C3805913
was	O
associated	O
with	O
death	O
(	O
OR	O
4.02	O
,	O
95	O
%	O
CI	O
1.84	O
-8.84	O
,	O
p	O
<	O
0.001	O
)	O
compared	O
with	O
peripheral	O
disease	I:C1704436
only	O
.	O

Peripheral	O
and	O
axial	O
disease	I:C3805913
was	O
associated	O
with	O
death	B:C1306577
(	O
OR	O
4.02	O
,	O
95	O
%	O
CI	O
1.84	O
-8.84	O
,	O
p	O
<	O
0.001	O
)	O
compared	O
with	O
peripheral	O
disease	I:C1704436
only	O
.	O

Peripheral	O
and	O
axial	O
disease	I:C3805913
was	O
associated	O
with	O
death	O
(	O
OR	O
4.02	O
,	O
95	O
%	O
CI	O
1.84	O
-8.84	O
,	O
p	O
<	O
0.001	O
)	O
compared	O
with	O
peripheral	B:C1704436
disease	I:C1704436
only	O
.	O

The	O
SIR	O
(	O
95	O
%	O
CI	O
)	O
for	O
a	O
CV	B:C1320716
event	I:C1320716
(	O
myocardial	O
infarction	I:C0027051
or	O
stroke	O
)	O
was	O
0.597	O
(	O
0.40	O
-	O
0.86	O
)	O
;	O
this	O
association	O
was	O
only	O
significant	O
in	O
men	O
.	O

The	O
SIR	O
(	O
95	O
%	O
CI	O
)	O
for	O
a	O
CV	O
event	I:C1320716
(	O
myocardial	B:C0027051
infarction	I:C0027051
or	O
stroke	O
)	O
was	O
0.597	O
(	O
0.40	O
-	O
0.86	O
)	O
;	O
this	O
association	O
was	O
only	O
significant	O
in	O
men	O
.	O

The	O
SIR	O
(	O
95	O
%	O
CI	O
)	O
for	O
a	O
CV	O
event	I:C1320716
(	O
myocardial	O
infarction	I:C0027051
or	O
stroke	B:C0018843
)	O
was	O
0.597	O
(	O
0.40	O
-	O
0.86	O
)	O
;	O
this	O
association	O
was	O
only	O
significant	O
in	O
men	O
.	O

The	O
SIR	O
(	O
95	O
%	O
CI	O
)	O
for	O
a	O
CV	O
event	I:C1320716
(	O
myocardial	O
infarction	I:C0027051
or	O
stroke	O
)	O
was	O
0.597	O
(	O
0.40	O
-	O
0.86	O
)	O
;	O
this	O
association	O
was	O
only	O
significant	O
in	O
men	B:C0025266
.	O

Patients	O
with	O
psoriatic	B:C0003872
arthritis	I:C0003872
had	O
a	O
small	O
but	O
significant	O
increase	O
in	O
SMR	O
for	O
death	O
due	O
to	O
diseases	O
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
compared	O
with	O
the	O
general	O
population	I:C0683971
.	O

Patients	O
with	O
psoriatic	O
arthritis	I:C0003872
had	O
a	O
small	O
but	O
significant	O
increase	O
in	O
SMR	O
for	O
death	B:C1306577
due	O
to	O
diseases	O
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
compared	O
with	O
the	O
general	O
population	I:C0683971
.	O

Patients	O
with	O
psoriatic	O
arthritis	I:C0003872
had	O
a	O
small	O
but	O
significant	O
increase	O
in	O
SMR	O
for	O
death	O
due	O
to	O
diseases	B:C0728936
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
compared	O
with	O
the	O
general	O
population	I:C0683971
.	O

Patients	O
with	O
psoriatic	O
arthritis	I:C0003872
had	O
a	O
small	O
but	O
significant	O
increase	O
in	O
SMR	O
for	O
death	O
due	O
to	O
diseases	O
of	I:C0728936
the	I:C0728936
circulatory	I:C0728936
system	I:C0728936
compared	O
with	O
the	O
general	B:C0683971
population	I:C0683971
.	O

Among	O
patients	O
,	O
death	B:C1306577
was	O
associated	O
with	O
DAI	O
,	O
as	O
well	O
as	O
axial	O
involvement	I:C3805913
in	O
combination	O
with	O
peripheral	O
disease	I:C1704436
,	O
indicating	O
more	O
aggressive	O
disease	O
phenotypes	O
.	O

Among	O
patients	O
,	O
death	O
was	O
associated	O
with	O
DAI	O
,	O
as	O
well	O
as	O
axial	B:C3805913
involvement	I:C3805913
in	O
combination	O
with	O
peripheral	O
disease	I:C1704436
,	O
indicating	O
more	O
aggressive	O
disease	O
phenotypes	O
.	O

Among	O
patients	O
,	O
death	O
was	O
associated	O
with	O
DAI	O
,	O
as	O
well	O
as	O
axial	O
involvement	I:C3805913
in	O
combination	O
with	O
peripheral	B:C1704436
disease	I:C1704436
,	O
indicating	O
more	O
aggressive	O
disease	O
phenotypes	O
.	O

